BIO-TECHNE (TECH) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $0.24.
- BIO-TECHNE's EPS (Weighted Average and Diluted) rose 14.29% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.49, marking a year-over-year decrease of 48.42%. This contributed to the annual value of $0.46 for FY2025, which is 56.19% down from last year.
- Per BIO-TECHNE's latest filing, its EPS (Weighted Average and Diluted) stood at $0.24 for Q3 2025, which was up 318.18% from -$0.11 recorded in Q2 2025.
- BIO-TECHNE's 5-year EPS (Weighted Average and Diluted) high stood at $1.69 for Q3 2021, and its period low was -$2.24 during Q2 2021.
- Its 3-year average for EPS (Weighted Average and Diluted) is $0.24, with a median of $0.24 in 2025.
- Per our database at Business Quant, BIO-TECHNE's EPS (Weighted Average and Diluted) slumped by 251.35% in 2021 and then surged by 116.96% in 2022.
- Over the past 5 years, BIO-TECHNE's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.49 in 2021, then plummeted by 36.73% to $0.31 in 2022, then crashed by 45.16% to $0.17 in 2023, then increased by 29.41% to $0.22 in 2024, then climbed by 14.29% to $0.24 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.24 for Q3 2025, versus -$0.11 for Q2 2025 and $0.14 for Q1 2025.